Testing effectiveness (Phase 2)Enrolling By InvitationNCT06751602
What this trial is testing
Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Who this might be right for
Rejection Chronic Renal
The Methodist Hospital Research Institute 40